1 Dec 2025Open access
Predictors of ICU Mortality in Septic Patients in a Resource-Limited African Setting: A Prospective Multicenter Cohort Study in Lubumbashi, DRCPublisher siteResearch Square, Sepsis Diagnosis and Treatment
Active, last published 2026
In malaria research and control
Hippolyte Nani-Tuma
Situakibanza
Scholar“Research focused on Malaria Research and Control and adjacent fields.”
Université de Kinshasa (UNIKIN)
DR Congo
Claim Your ProfileDR Congo4
H-index
85
Citations
Hippolyte has not officially claimed their profile. If you are Hippolyte, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ippolyte Nani-Tuma Situakibanza is a researcher working on Malaria Research and Control. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Hippolyte's work has been cited 85 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Malaria Research and Control×6COVID-19 Clinical Research Studies×5SARS-CoV-2 and COVID-19 Research×4Mosquito-borne diseases and control×4Hepatitis C virus research×3
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Kinshasa, DR CongoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
15 works27 Oct 2025Open access
Adult patients with sepsis in the ICU in Lubumbashi, Democratic Republic of CongoPublisher siteCritical Care, Sepsis Diagnosis and Treatment
16 Jul 2025Open access1cites
Bacteriological profile and antimicrobial resistance in sepsis cases in intensive care units in Lubumbashi: challenges and perspectivesPublisher siteAnnals of Clinical Microbiology and Antimicrobials, Sepsis Diagnosis and Treatment
11 Mar 2025Open access
Incidence of dynamic seroconversion in subjects received the first dose of the SARS-COV-2 vaccine (AstraZeneca, Moderna and Pfizer) in Kinshasa, Democratic Republic of Congo: prospective cohort studyPublisher siteBMC Infectious Diseases, SARS-CoV-2 and COVID-19 Research
11 Feb 2025Open access1cites
Service availability and readiness of tuberculosis units’ clinics to manage diabetes mellitus in Lubumbashi, Democratic Republic of the CongoPublisher siteBMC Health Services Research, Tuberculosis Research and Epidemiology
19 Dec 2023Open access
Efficacy and Safety of African Medicinal plants in the treatment of mild or moderate COVID-19: a randomized clinical trial using Doubase C ®Publisher siteResearch Square, Diverse Scientific Research Studies
13 Dec 2023Open access
Evolving profile of severe and critical COVID-19 according: Cases admitted to the University Hospital of Kinshasa (UHK) = the official name of the institution from March 24, 2020 to December 12, 2022Publisher siteResearch Square, COVID-19 Clinical Research Studies
1 Jan 2023Open access1cites
Étude interventionnelle sur le Dolutégravir et les autres antirétroviraux dans l´athérosclérosclérose infra-clinique en milieu hospitalier de KinshasaPublisher sitePan African Medical Journal, HIV-related health complications and treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Hippolyte?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you